This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

New Study Associates FORE-SIGHT Cerebral Oximetry With Lactate Flux In The Brain Of Patients Undergoing Carotid Endarterectomy

BRANFORD, Conn., Aug. 25, 2010 (GLOBE NEWSWIRE) -- CAS Medical Systems, Inc. (Nasdaq:CASM) today announced a new study to be published in the Canadian Journal of Anesthesia. The study from researchers in the Departments of Anesthesia and Surgery, at the University of Manitoba, Winnipeg, MB, Canada examined the correlation between a variety of point-of-care monitors and lactate flux, an indicator of metabolic stress during carotid endarterectomy (CEA).

There are approximately 140,000 CEA procedures performed in the U.S. every year. The ability to assess the brain-at-risk during CEA under general anesthesia remains a major clinical challenge. A monitor that quickly alerts anesthesiologists in real-time of the potential for cerebral injury during CEA would be of considerable value to enhance the safety of this procedure. The authors note that "the ideal point-of-care monitor specific to anesthesia can accurately predict when an organ is at risk during an operative procedure so that a therapeutic intervention can be initiated to prevent further or permanent damage to that organ."

The authors theorize that the body introduces lactate into the brain to serve as a critically important fuel for cerebral metabolism when the brain is faced with diminished oxygen supply, such as occurs during cross clamp in the CEA procedure. Results from this observational study suggest that large changes in cerebral tissue saturation (SctO2) as measured by the FORE-SIGHT ® Absolute Oximeter may provide a surrogate for measuring lactate changes during the CEA procedure.

When assessing point-of-care monitors for correlation and identification of lactate changes, the authors suggest that the non-invasive FORE-SIGHT monitor may aid in the management of patients undergoing CEA during general anesthesia. Authors found that FORE-SIGHT Absolute Cerebral Oximetry "…correlated well with lactate flux – indicating the brain under stress."  While FORE-SIGHT responded "within seconds" to lactate flux, the other tested point-of-care monitoring techniques (i.e., BIS, DSA and EEG) either failed to correlate or were very slow. The study concluded that alternative point-of-care monitors, such as processed EEG, either by EEGo or BIS, were "not quantitative enough or sensitive enough to indicate patients at risk."

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
CASM $2.00 0.00%
AAPL $93.66 -0.09%
FB $118.57 0.84%
GOOG $698.30 0.76%
TSLA $241.82 0.44%


Chart of I:DJI
DOW 17,891.16 +117.52 0.66%
S&P 500 2,081.43 +16.13 0.78%
NASDAQ 4,817.5940 +42.2360 0.88%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs